STAT Virtual Event: The State of Biosimilars: What to Watch
Join STAT for a discussion of what’s next for biosimilars, and what key signals will indicate how they might be prescribed, or paid for.
Join STAT for a discussion of what’s next for biosimilars, and what key signals will indicate how they might be prescribed, or paid for.
Rick Slayman, a Massachusetts man who received the first kidney transplant from a CRISPR-edited pig, has died almost two months after the xenotransplant.
Excision BioTherapeutics reported Friday that an early trial failed to cure HIV patients, but the company plans to try again with a more efficient editing…
After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment.
Sanofi on Friday said it had reached a deal worth up to $1.2 billion to sell Novavax’s Covid shot as well as to try to…
More and more studies show that alcohol isn’t healthy after all. Dietary guidelines are up for revision in 2025, and already, there’s debate over research…
The CDC has refused to make exceptions for military personnel or government employees importing their pets.
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their…
Check out the latest edition of Adam’s Biotech Scorecard, a new newsletter from @statnews.
U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, BIO says.
Diagnosis, treatment, monitoring and access can pose problems for both patients and their doctors, experts said at a STAT virtual event Wednesday.